10-102810037-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001083913.2(WBP1L):c.338C>T(p.Ala113Val) variant causes a missense change. The variant allele was found at a frequency of 0.00008 in 1,612,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )
Consequence
WBP1L
NM_001083913.2 missense
NM_001083913.2 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.96
Genes affected
WBP1L (HGNC:23510): (WW domain binding protein 1 like) Predicted to enable ubiquitin protein ligase binding activity. Predicted to act upstream of or within CXCL12-activated CXCR4 signaling pathway; hemopoiesis; and positive regulation of protein ubiquitination. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08607876).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WBP1L | NM_001083913.2 | c.338C>T | p.Ala113Val | missense_variant | 3/4 | ENST00000448841.7 | NP_001077382.1 | |
WBP1L | NM_017787.5 | c.275C>T | p.Ala92Val | missense_variant | 3/4 | NP_060257.4 | ||
WBP1L | XM_011539913.3 | c.311C>T | p.Ala104Val | missense_variant | 3/4 | XP_011538215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WBP1L | ENST00000448841.7 | c.338C>T | p.Ala113Val | missense_variant | 3/4 | 2 | NM_001083913.2 | ENSP00000414721.1 | ||
WBP1L | ENST00000369889.5 | c.275C>T | p.Ala92Val | missense_variant | 3/4 | 1 | ENSP00000358905.4 | |||
WBP1L | ENST00000647664.1 | n.338C>T | non_coding_transcript_exon_variant | 3/8 | ENSP00000498131.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000156 AC: 39AN: 249436Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134848
GnomAD3 exomes
AF:
AC:
39
AN:
249436
Hom.:
AF XY:
AC XY:
14
AN XY:
134848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000726 AC: 106AN: 1460126Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 726422
GnomAD4 exome
AF:
AC:
106
AN:
1460126
Hom.:
Cov.:
31
AF XY:
AC XY:
42
AN XY:
726422
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74348
GnomAD4 genome
AF:
AC:
23
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.338C>T (p.A113V) alteration is located in exon 3 (coding exon 3) of the WBP1L gene. This alteration results from a C to T substitution at nucleotide position 338, causing the alanine (A) at amino acid position 113 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
0.27
.;Gain of sheet (P = 0.1539);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at